Home » Topics » Regulatory

Regulatory
RSS

Canadian authorities approve use of Fragmin in treatment of heart disease

Aug. 31, 1998

Hoechst Marion Roussel and 3M file NDA for QVAR

Aug. 28, 1998

CIBIS-II study results confirm benefits of beta-blockade in heart failure

Aug. 27, 1998

FDA approves first treatment for Crohn's disease

Aug. 27, 1998

MOXCON study will test the efficacy of SIRAs in treating heart failure

Aug. 27, 1998

SSRI produces significant improvements in patients with social phobia

Aug. 26, 1998

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...